Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
HU-446 and HU-465, derivatives of the non-psychoactive cannabinoid cannabidiol, decrease the activation of encephalitogenic T cells.
High prevalence of sickness absence and disability pension among multiple sclerosis patients: a nationwide population-based study.
Therapeutic Apheresis in Pediatric Patients with Acute CNS Inflammatory Demyelinating Disease.
Are There Differences in the Prevalence of Palliative Care-Related Problems in People Living With Advanced Cancer and Eight Non-Cancer Conditions? A Systematic Review.
Author response.
Equivalence of Glatiramer Acetate Generics With Branded Glatiramer Acetate in Efficacy and Cost for the Treatment of Multiple Sclerosis.
Pediatric multiple sclerosis: pathobiological, clinical, and magnetic resonance imaging features.
Neurogenic detrusor overactivity is associated with decreased expression and function of the large conductance voltage- and ca(2+)-activated k(+) channels.
Multiple sclerosis: Daclizumab HYP shows superiority to IFN-β1a for reducing relapses in multiple sclerosis.
Treatment of acute relapses in neuromyelitis optica: Steroids alone versus steroids plus plasma exchange.
The molecular physiology of the axo-myelinic synapse.
Gender influence on schizophrenia-relevant abnormalities in a cuprizone demyelination model.
[Inflammation of the optic nerve: when it should be considered as neuromyelitis optica--the experience of the Department of Neurology at Hadassah Hospital].
Abnormal distribution of AQP5 in labial salivary glands is associated with poor saliva secretion in patients with Sjögren's syndrome including neuromyelitis optica complicated patients.
Neuroprotection and immunomodulation by xenografted human mesenchymal stem cells following spinal cord ventral root avulsion.
Pushing the boundaries of neuromyelitis optica: Does antibody make the disease?
A Further TWEAK to Multiple Sclerosis Pathophysiology.
Multiple sclerosis: Preventing progression and disability in MS-when to treat?
Olanzepine-induced neuroleptic malignant syndrome in a case of multiple sclerosis.
Sexual dimorphism in the aged rat CD4+ T lymphocyte-mediated immune response elicited by inoculation with spinal cord homogenate.
Clinical Feasibility of Synthetic MRI in Multiple Sclerosis: A Diagnostic and Volumetric Validation Study.
Neuromuscular manifestations of west nile virus infection.
Paraneoplastic neuromyelitis optica spectrum disorder associated with stomach carcinoid tumor.
Role of Glycine N-methyltransferase in The Regulation of T Cell Responses in Experimental Autoimmune Encephalomyelitis.
Treatment Against Human Endogenous Retrovirus: A Possible Personalized Medicine Approach for Multiple Sclerosis.
Pages
« first
‹ previous
…
480
481
482
483
484
485
486
487
488
…
next ›
last »